# AMETEK, Inc

> Clarifo company profile — qualitative business description generated from
> the company's filings. Financial statements, charts and ratios are
> available on Clarifo (https://www.clarifo.com/en/companies/AMETEK, Inc).

## Overview

AMETEK, Inc. is a Delaware-incorporated industrial technology company that manufactures electronic instruments and electromechanical devices used in demanding, application-specific environments. It operates through two groups—Electronic Instruments (EIG) and Electromechanical (EMG)—selling into process and power markets, aerospace and defense platforms, medical devices, and factory automation. The company’s model emphasizes engineered niches, recurring aftermarket activity in certain aerospace applications (spares, repair and overhaul), and an acquisition-driven portfolio strategy. AMETEK is headquartered in Berwyn, Pennsylvania and sells globally across North America, Europe, Asia, and South America.

## Products & services

• Process, power & industrial measurement and control instruments
• Aerospace instruments and sensing/monitoring solutions
• Precision motion control systems for automation applications
• Medical components: single-use instruments, implants, drug delivery
• Thermal management: motor-blowers and heat exchangers
• Electrical interconnects, connectors, and electronics packaging
• Specialty metals: metal powder, strip, wire and bonded products

- **Electronic Instruments (EIG)** (60%) — Advanced instruments for process, power & industrial and aerospace markets, including measurement, monitoring and control solutions.
- **Precision motion control & automation (EMG)** (15%) — Highly engineered motion control solutions used in medical, semiconductor, aerospace/defense and industrial automation applications.
- **Medical components & devices (EMG)** (10%) — Single-use/consumable surgical instruments, implantable components and drug delivery systems sold to medical OEMs.
- **Thermal management & aerospace MRO (EMG)** (10%) — Motor-blower systems, heat exchangers and third-party MRO services supporting commercial and military aerospace platforms.
- **Electrical interconnects & specialty metals (EMG)** (5%) — Harsh-environment connectors/electronics packaging and specialty metal powders/strip/wire for industrial, medical and defense uses.

- Process, power & industrial measurement and control instruments
- Aerospace instruments and sensing/monitoring solutions
- Precision motion control systems for automation applications
- Medical components: single-use instruments, implants, drug delivery
- Thermal management: motor-blowers and heat exchangers
- Electrical interconnects, connectors, and electronics packaging
- Specialty metals: metal powder, strip, wire and bonded products

## Customers

AMETEK primarily sells to OEMs and industrial customers that require high-reliability instruments and engineered components, often tailored to specific platforms or regulated applications. EIG serves process, power and industrial customers as well as aerospace programs, with sales frequently routed through distribution in some markets, which can reduce near-term demand visibility. EMG’s customer base includes aerospace and defense OEMs and integrators, medical device manufacturers buying consumables and implantable components, and automation customers in areas such as semiconductor and food and beverage. The company also participates in aerospace aftermarket through spare parts, repair and overhaul services, which can add recurring revenue streams tied to fleet utilization. Customer concentration is limited: in 2025, EIG’s five largest customers represented ~4% of EIG sales and EMG’s five largest customers represented ~15% of EMG sales, with no single customer above 2% of total net sales in EIG and above 5% in EMG.

- **Aerospace and defense OEMs & integrators** (primary) — Buy aerospace instruments, thermal management systems, connectors and qualified components for commercial and military platforms where reliability and certification matter.
- **Industrial process, power and general industrial customers** (primary) — Purchase electronic instruments for measurement, monitoring and control to improve uptime, compliance and process efficiency in plants and infrastructure.
- **Medical device manufacturers** (secondary) — Source engineered medical components such as single-use surgical instruments, implantable components and drug delivery systems for regulated medical applications.
- **Automation and semiconductor equipment ecosystem** (secondary) — Use precision motion control and automation solutions to enable high-accuracy positioning and throughput in advanced manufacturing environments.
- **Aftermarket/MRO customers (aerospace)** (emerging) — Buy spare parts and third-party repair/overhaul services to keep aircraft and related systems operating, tied to installed base and utilization.

- Aerospace OEMs and system integrators buying qualified components/instruments
- Commercial aerospace operators using spares, repair and overhaul services
- Process and power plants needing measurement, monitoring and control tools
- Medical device OEMs sourcing single-use instruments and implantables
- Automation customers needing precision motion control for production lines
- Defense programs requiring harsh-environment connectors and packaging
- Distributors in certain markets, reducing direct demand visibility

## Geography

AMETEK operates globally with sales across North America, Europe, Asia and South America, supported by a distributed manufacturing and service footprint. The company highlighted international expansion as a growth driver, with Europe described as its largest overseas market and additional emphasis on emerging markets in Asia, Latin America and the Middle East. In Q2 2025, international sales were 47.4% of net sales, indicating a near-even split between U.S. and non-U.S. demand and meaningful exposure to foreign currency translation. Manufacturing and best-cost operations include facilities in China, Czechia, Malaysia, Mexico and Serbia, which also help localize production and mitigate tariff impacts. The company also maintains aerospace MRO capabilities with facilities in the United States, Europe and Asia.

- **International (non-U.S.)** (47.4%) — Q2 2025 international sales as % of net sales (10-Q).
- **United States** (52.6%) — Implied as remainder of Q2 2025 net sales (100% - 47.4%).

- Global sales footprint across North America, Europe, Asia and South America
- International sales were 47.4% of net sales in Q2 2025
- Europe cited as the largest overseas market in expansion strategy
- Best-cost manufacturing in China, Czechia, Malaysia, Mexico and Serbia
- Worldwide footprint used to localize production amid tariff uncertainty
- Aerospace MRO facilities located in the U.S., Europe and Asia
- Meaningful FX translation exposure due to non-U.S. revenue mix

## Strategy

AMETEK runs its operating playbook through the AMETEK Growth Model, centered on Operational Excellence, Strategic Acquisitions, Global & Market Expansion, and New Products. Operational Excellence focuses on lean, flexible manufacturing and best-cost footprints to support margins and responsiveness, while global expansion builds sales, service and engineering capabilities closer to customers. The company prioritizes capital deployment toward acquisitions, using cash generation to add differentiated technologies and expand its international presence, with recent deals including Virtek, Kern, FARO and the post-year-end acquisition of LKC Technologies (to join EIG). New product development is treated as a sustained investment, supported by Design for Six Sigma, value engineering and AI tools to increase the pace and quality of product introductions. AMETEK also emphasizes talent development as a prerequisite to executing this model and maintains a policy of consistently increasing dividends.

- **Strategic, value-enhancing acquisitions** (medium-term) — Acquisitions expand the portfolio into differentiated niches and add international presence and capabilities.
- **Operational Excellence and best-cost manufacturing footprint** (short-term) — Lean and flexible operations support margin resilience, delivery performance and tariff/supply-chain mitigation.
- **New product development in secular growth markets** (long-term) — Differentiated technology and steady product refresh supports pricing power and share in niche applications.

- Operational Excellence to drive lean, flexible, best-cost manufacturing
- Strategic acquisitions to add differentiated niches and technologies
- Global & market expansion via sales/service/engineering build-out
- New product development using DFSS, VA/VE and AI tools
- Supply chain localization to mitigate tariffs and trade disruptions
- Maintain increasing dividend while funding M&A and organic investment

## Risks

AMETEK’s results are exposed to cyclical end markets—particularly aerospace and defense, oil and gas, process instrumentation and power—so a downturn or slower-than-expected growth can reduce orders and make quarterly performance harder to forecast. International operations create sensitivity to tariffs, trade restrictions and retaliatory actions, as well as foreign currency translation, and the company noted uncertainty around evolving U.S. tariff negotiations. The acquisition-led strategy adds integration and execution risk, including the possibility that acquired businesses dilute margins or fail to deliver expected synergies. Like other industrial technology manufacturers, AMETEK faces supply chain and raw material availability/price risks that can pressure costs and delivery schedules. The company also highlighted cybersecurity and IT disruption risk, including third-party managed systems and the potential for ransomware or AI-enabled attacks to interrupt operations or expose sensitive data.

- **End-market cyclicality and macro downturn** [high] — Demand is tied to cyclical industries (aerospace/defense, oil & gas, process instrumentation, power) and order timing is difficult to forecast quarter-to-quarter.
- **Tariffs, trade disputes and related supply chain adjustments** [high] — Tariffs and trade restrictions can increase input costs, disrupt supply chains and reduce demand; outcomes of negotiations were described as uncertain.
- **Cybersecurity and IT system disruption** [high] — Attacks (including ransomware and AI-enabled threats) could interrupt order fulfillment, production and shipments, and create legal/regulatory exposure for sensitive data.
- **Acquisition execution and integration risk** [medium] — Growth strategy relies on acquisitions; failure to integrate or realize expected performance can impair returns and disrupt operations.

- Cyclicality in aerospace/defense, oil & gas, process and power markets
- Order timing and limited visibility (especially via distribution channels)
- Tariffs/trade restrictions can raise costs and reduce demand
- Foreign currency translation impacts due to sizable international sales
- Acquisition integration risk and potential margin dilution
- Raw material price/availability and supply chain disruption risk
- Cybersecurity incidents could disrupt operations and trigger liabilities

## Accounting

AMETEK’s acquisition-heavy strategy makes purchase accounting a critical area: management must allocate purchase price across tangible assets, identifiable intangibles and goodwill, including fair value of contingent consideration, using significant assumptions (discount rates, future cash flows and economic lives). Goodwill impairment testing is judgmental and relies on discounted cash flow models and long-range plans; changes in market conditions or forecast performance can lead to impairment charges. Because the company sells engineered products across many end markets and geographies, investors should expect revenue and margin comparability to be influenced by acquisition timing, integration costs and foreign currency translation effects. The company also carries meaningful cash outside the U.S., which can affect tax, liquidity planning and cash flow presentation depending on repatriation and deployment decisions. Overall, fair value measurements and estimates around M&A and impairment are likely to be among the most consequential drivers of reported earnings volatility.

- **Business combinations (purchase accounting)** — Drives goodwill/intangible balances, amortization expense and potential future charges.
- **Goodwill impairment testing** — Potential non-cash impairment charges and reduced equity.

- Purchase price allocation for acquisitions drives goodwill/intangibles
- Contingent consideration fair value requires significant estimates
- Goodwill impairment testing uses DCF and long-range plan assumptions
- Key assumptions include discount rates, cash flows and useful lives
- Acquisition timing/integration costs can affect period-to-period margins
- Foreign currency translation affects reported sales and profitability
- Cash held outside the U.S. can influence tax and cash flow analysis

---

*Last updated: 2026-09-24T12:23:11.356785+00:00*